Check-Cap(us:CHEK)

0.7730

-2.15%

Updated on 2025-03-31

Open:0.7700
Close:0.7730
High:0.8010
Low:0.7700
Prev Close:0.7900
Volume:8602.00
Turnover:6675.88
Turnover Ratio:0.15%
Shares:5.85M
MarketCap:4.52M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-301364040.11%105
2024-03-311267170.11%215
2023-12-3116623201.07%217
2023-09-3014222520.38%213
2023-06-3017110420.19%2110
2023-03-31191452752.48%327
2022-12-3124940061.61%479
2022-09-3026423860.04%249
dateorgNametotalratiochangeShareschangeRatio
2024-03-31Morgan Stanley35970.06%-1700-32.09%
2024-03-31Osaic Holdings, Inc.21220.04%-10-0.47%
2024-03-31Qube Research & Technologies Ltd3000.01%300
2024-03-31Bank Of America Corp /De/3000.01%0
2024-03-31Concourse Financial Group Securities, Inc.2130.00%0
2024-03-31Royal Bank Of Canada1100.00%0
2024-03-31Northwestern Mutual Wealth Management Co530.00%501666.67%
2024-03-31Bogart Wealth, Llc140.00%14
2024-03-31Jnba Financial Advisors50.00%0
2024-03-31Ubs Group Ag30.00%-5184-99.94%

About

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
Address:29 Abba Hushi Avenue,Check-Cap Building

Market Movers